Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Neurogenic aspects of essential hypertension in man

  • 16 Accesses

  • 1 Citations

This is a preview of subscription content, log in to check access.

References

  1. Adler-Graschinsky, E. and Langer, S. Z. 1975. Possible role of the beta adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a posture feedback mechanism. Br. J. Pharmacol. 53, 43.

  2. Altura, B. 1975. Pharmacological effects of alpha methyldopa, alpha methylnorepinephrine and octopamine on rat arteriolar arterial and terminal vascular smooth muscle. Circ. Res. Spl. 1, 36 (1-233)–(1-240).

  3. Armstrong, J. M. and Boura, A. L. A. 1973. Effects of clonidine and guanethidine on periuheral sympathetic nerve function in the pithed rat. Br. J. Pharmacol. 47, 850.

  4. Baillie, T. A., Boobis, A. R., Davies, D. S., Jones, D. H., Murray, S. and Reid, J. L. 1977. Studies on the metabolic fate of MHPG in man. Br. J. Pharmacol. 60(2), 280P.

  5. Baldessarini, R. J. 1975. Release of catecholamines.In: Handbook of Psychopharmacology 3. Eds. L. L. Iversen, S. D. Iverson and S. H. Enyder. New York-London, Plenum. p. 37.

  6. Blaustein, M. P. and Oborne, C. J. 1975. The influence of sodium on calcium fluxes in pinched off nerve terminalsin vitro. J. Physiol. 247, 657.

  7. Brown, J. J., Fraser, R., Lever, A. F., Mason, P., Morton, J. J., Robertson, J. I. S., Schalekamp, M. A. and Semple, P. F. 1976. Reinin angiotensin aldosterone in hypertension.In: Advanced Medicine. 12. Ed. D. K. Peters. London. Pitman. p. 407.

  8. Brown, G. L. and Gillespie, J. S. 1957. The output of sympathetic transmitter from the spleen of the cat. J. Physiol. 138, 81.

  9. Bryan, Holland, O. and Kaplan, N. 1976. Propranolol in the treatment of hypertension. New Eng. J. Med. 294, 930.

  10. Chalmers, J. P. 1975. Brain amines and models of experimental hypertension. Circ. Res. 36, 469.

  11. Chalmers, J. P. 1978. Nervous system and hypertension. Clin. Sci. Mol. Med. 55, Spl. 4, 453.

  12. Chuang, D. M. and Costa, E. 1974. Biosynthesis of tyrosine hydroxylase in rat adrenal medulla after cold exposure. Proc. Nat. Acad. Sci. 71, 4570.

  13. Chubb, I. W. and Raine, A. E. G. 1976. Long term effects of propranolol on tyrosine hydroxylase and dopamine beta hydroxylase in the superior cervical ganglia of the rabbit. Br. J. Pharmacol. 58, 430P.

  14. Cryer, P. E., Haymond, M. W., Santiago, J. V. and Shah, S. D. 1976. Norepinephrine and epinephrine release and adrenergic mediation of smoking associated haemodynamic and metabolic events. New Eng. J. Med. 295, 573.

  15. Da Prada, M. and Zurcher, G. 1976. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the fentomole range. Life Sci. 19, 1161.

  16. Dargie, H. D., Dollery, C. T., Watkins, J. and Fitz-Gerald, G. A. 1979. The clinical pharmacology of prazocin. Excerpta Medica (in press).

  17. Dousse, J. P., Miach, P. J., Elghozi, C., Lecy-Marchal, C. and Meyer, P. 1979. Biochemical studies of alpha adrenergic receptors in the rat brain.In: Nervous System and Hypertension. Eds. P. Myer and H. Schmitt. Paris. Flammarion.

  18. de Champlain, J. 1976. Evaluation of the neurogenic component in human hypertension.In: The Nervous System in Arterial Hypertension. Eds. J. Julius and M. D. Esler. Springfield. Charles C. Thomas. p. 267.

  19. de Champlain, J. 1978. The sympathetic system in hypertension.In: Clinics in Endocrinology and Metabolism. Ed. L. Landsberg. London. W. B. Saunders. p. 633.

  20. de Champlain, J., Fairley, L., Cousineau, D. and Van Amerigan, M. R. 1976. Circulating catecholamine levels in human and experimental hypertension. Circ. Res. 38, 109.

  21. de Quattro, V. and Chan, S. 1972. Raised plasma catecholamines in some patients with primary hypertension. Lancet i, 806.

  22. de Quattro, V., Campese, V., Miuray, C. and Meijer, D. J. 1976. Increased plasma catecholamines in high renin hypertension. Am. J. Cardiol. 38 (Spl. 6), 801.

  23. Dollery, C. T., Reid, J. L., Dean, C. R. T. and Mayling, T. 1979. Evidence for and against a hypotensive action of propranolol medicated by a nervous system beta receptor.In: Nervous Nervous System and Hypertension. Eds. P. Myer and H. Schmitt. Paris. Flammarion. p. 344.

  24. Drew, G. M. 1978. Pharmacological characterization of the presynaptic alpha adrenoceptors regulating cholinergic activity in the guinea pig ileum. Br. J. Pharm. 64, 293.

  25. Dryer, G. P. 1898. On secretory nerves to the supraneural capsules. Am. J. Phys. 2, 203.

  26. Dubocovich, M. L., Langer, S. Z. and Pelayo, F. 1978. Effect of cyclic nucleotides on3H-neurotransmitter release induced by potassium stimulation in the rat pineal gland. Br. J. Pharmacol. 62, 383P.

  27. Ebert, M. and Kopin, I. J. 1975. Differential labelling of origins or urinary metabolites by dopamine—14C. Trans. Ass. Am. Phys. 88, 256.

  28. Engleman, K. 1978. Phaeochromocytoma.In: Clinics in Endocrinology and Metabolism. 6. Ed. L. Landsberg. London. W. B. Saunders Company. p. 769.

  29. Engelman, K., Portnoy, B. and Sjoerdsma, A. 1970. Plasma catecholamine concentrations in patients with hypertension. Circ. Res. 27 (Supl. 1) 1.

  30. Esler, M., Zweigler, A., Randall, O., Julieus, S. and de Quattro, V. 1977. Agreement among 3 different indices of sympathetic nervous system activity in essential hypertension. Mayo Clin. Proc. 52, 379.

  31. Folkow, B. 1978. Cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension. Clin Sci. Mol. Med. 55, 3s.

  32. Folkow, B., Grimby, G. and Thulesius, O. 1958. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Phys. Scand. 44, 255.

  33. Folkow, B., Hallbäck, M., Lundgren, Y., Silvertsson, R. and Weiss, L. 1973. Importance of adaptive changes in vascular design for establishment of primary hypertension studied in man and in spontaneously hypertensive rats. Circ. Res. 32–33, suppl. 2–16.

  34. Fillenz, M. and Pollard, R. M. 1976. Quantitative differences between sympathetic nerve terminals. Brain Res. 109, 443.

  35. FitzGerald, G. A., Hossmann, V., Davies, D. S. and Dollery, C. T. 1979a. Interindividual variation in norepinephrine kinetics in man. Clin. Pharm. Ther. (in press).

  36. FitzGerald, G. A., Hossmann, V. and Dollery, C. T. 1979b. Noradrenaline release in essential hypertension. Proceedings of the European Society of Clinical Investigation, Cambridge. Eur. J. Clin. Invest. 9, part 2, 11.

  37. FitzGerald, G. A., Barnes, P., Hamilton, C. A. and Dollery, C. T. 1979c. Concentration-effect relationships and kinetics of adrenaline in man. Br. J. Clin. Pharm. (in press).

  38. FitzGerald, G. A., Hamilton, C. A., Jones, D. H. and Reid, J. L. 1979d. Red cell catechol-O-methyl transferase and indices of sympathetic activity in man. Clin. Sci. Mol. Med. (in press).

  39. Franco-Morselli, R., Elghozi, J. L., Joly, E., di Giulio, S. and Myer, P. 1977. Increased plasma adrenaline concentrations in benign essential hypertension. Br. Med. J. ii, 1251.

  40. Gillespie, J. S. 1972. Uptake of noradrenaline by smooth muscle. Br. Med. Bull. 29, 136.

  41. Goodall, McC. and Kirshner, N. 1957. Biosynthesis of adrenaline and noradrenalinein vitro. J. Biol. Chem. 226, 213.

  42. Gray, E. G. 1976. Microtubules in the synapses of the retina. J. Neurocytol. 5, 361.

  43. Gray, E. G. 1977. Presynaptic microtubules, agranular reticulum and synaptic vesicles.In: Synapses. G. A. Cottrell, P. N. N. R. Usherwood. Blackie. p. 6.

  44. Haeusler, G. 1979. Electrophysiological studies on the transmission through the first synapse of the baroflex arc.In: Nervous System and Hypertension. Eds. P. Myer and H. Schmitt. Paris. Flammarion. p. 209.

  45. Häggendal, J., Johansson, B., Jonason, J. and Ljung, B. 1972. Effects of phenoxybenzamine on transmitter release and effector response in isolated portal vein. J. Pharm. Pharmac. 24, 161.

  46. Hamilton, C. A., Jones, D. H., Dargie, H. J. and Reid, J. L. 1978. Does labetalol increase excretion of urinary catecholamines? Br. Med. J. ii, 800.

  47. Hanbauer, I, Kopin, I. J., Guidotti, A. and Costa, E. 1975. Dexamethasone induces tyrosine hydroxylase in sympathetic ganglia but not in adrenal medulla. Brain Res. 85, 527.

  48. Henderson, G., Hughes, J. and Kosterlitz, H. W. 1979. Modification of catecholamine release by narcotic analgesics and opiate peptides.In: The Release of Catecholamines from Adrenergic Neurons. Ed. D. M. Paton. Oxford. Pergamon. p. 217.

  49. Henry, D. P., Starman, B. J., Johnson, D. G. and Williams, R. H. 1975. A sensitive radioenzymatic assay for norepinephrine in tissue and plasma. Life Sci. 16, 375.

  50. Herz, A. and Teschemacher, H. J. 1971. Activities and sites of antinociceptive action of morphine like analgesics and kinetics of distribution following intravenous intracerebral and intraventricular application. Advanc. Drug Res. 6, 79.

  51. Heuser, J. E., Reese, T. S. and Landis, D. M. D. 1976. Preservation of synaptic structure by rapid freezing. Cold Spr. Harb. Symp. 49, 17.

  52. Hokfelt, B., Hedeland, H. and Dymling, J. F. 1970. Studies on catecholamines, renin and aldosterone following catepresan R in hypertensive patients. Eur. J. Pharmacol. 10, 389.

  53. Hörtnagel, H., Stadler-Wolffersgrin, R., Brüche, T. L., Hammerle, A. and Hackl, J. M. 1978. Changes of dopamine beta hydroxylase activity in human plasma during prolonged overactivity of the sympathetic nervous system in various diseases. Naaunyn. Schmiedebergs Arch Pharmacol. 302, 48.

  54. Hossmann, V., FitzGerald, G. A., Dean, C. R. T. and Dollery, C. T. 1978. Circadian rhythm of blood pressure and adrenergic vascular activity. Chronobiologia 5, 190.

  55. Inversen, L. L. 1965. The inhibition of noreadrenaline uptake by drugs. Adv. Drug Research 2, 5.

  56. Inversen, L. L. 1967.In: The Uptake and Storage of Noradrenaline in Sympathetic Nerves. Cambridge University Press. p. 1.

  57. Iversen, L. L. 1972. Catecholamine uptake processes. Br. Med. Bull. 29, 130.

  58. Jones, D. H., Reid, J. L. and Allison, D. J. 1978. Diagnosis of phaeochromocytoma by compared axial tomographic scan and other methods. N. Eng. J. Med. 299, 1469.

  59. Jones, D. H., Hamilton, C. A. and Reid, J. L. 1978. Plasma noradrenaline, age and blood pressure: a population study. Clin Sci. Mol. Med. 55, 733.

  60. Kobinger, W. 1978. Central alpha adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol. 81, 1.

  61. Kopin, I. J. 1978. Catecholamine metabolism.In: Clinics in Endocrinology and Metabolism 6. Ed. L. Landsberg. London. W. B. Saunders Company. p. 523.

  62. Kopin, I. 1979. Plasma catecholamines in hypertension.In: Nervous System and Hypertension Eds. P. Myer and H. Schmitt. Paris. Flammarion. p. 267.

  63. Kopin, I. J., Breese, G. R., Krauss, K. R. and Weise, V. 1968. Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J. Pharmacol. Exp. Ther. 161, 271.

  64. Kosterlitz, H. W. and Lees, G. M. 1972. Interrelationships between adrenergic and cholinergic mechanisms.In: Catecholamines: Handbuch der experimentellen Pharmakologie. Eds. H. Blaschko and E. Muscholl. Berlin-Heidelburg-New York, Springer. p. 762.

  65. Kristensen, B. O. 1978. Increased serum levels of immunoglobulins in untreated and treated essential hypertension. Acta Med. Scand. 203, 49.

  66. Kristensen, B. O., Anderson, P. L., Lamm, L. U. and Kissmeyer-Nielsen, F. 1977. HLA antigens in essential hypertension, relation to familion disposition and serum immunoglobulins. Tissue Antigen 10, 70.

  67. Lake C. R., Ziegler, M. C., Coleman, M. D. and Kopin, I. J. 1977. Age adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. New Eng. J. Med. 296, 208.

  68. Langer, S. Z. and Enero, M. A. 1974. The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: its relationship to the metabolic fate of released norepinephrine. J. Pharmacol. Exp. Ther. 191, 431.

  69. Langer, S. Z. 1974. Presynaptic regulation of catecholamine release. Biochem. Pharmac. 23, 1973.

  70. Langer, S. Z. 1979. Presynaptic receptors and regulation of release.In: The Release of Catecholamines from Adrenergic Neurons. Ed. D. M. Paton. Oxford. Pergamon. p. 59.

  71. Langer, S. Z., Dubocovich, M. L. and Celuch, S. M. 1975. Prejunctional regulatory mechanisms for noradrenaline release elicited by nerve stimulation.In: Chemical Tools in Catecholamine Research II. Eds. C. Almgren A. Carlsson and J. Engel. Amsterdam. Elsevier-North Holland. p. 183.

  72. Matthews, E. K. and Nordmann, J. J. 1976. The synaptic vesicle: calcium ion binding to the vesicle membrane and its modification by drug action. Mol. Pharmacol. 12, 778.

  73. Matthews, J. D., Mathieson, I. D. and Tait, B. D. 1979. Proc. I Int. Symp. Immunol. Arteriosclerosis (in press).

  74. Miura, Y., Campese, V., de Quattro, V. and Meijer, D. 1977. Plasma catecholamines via an improved fluorometric assay —a comparison with radioenzymatic method. J. Lab. Clin. Med. 89, 421.

  75. Mitchell, J. R., Taylor, A. A., Pool, J. L., Lake, C. R., Rollins, D. E. and Bartter, F. C. 1977. Renin aldosterone profiling in hypertension. Ann. Int. Med. 87, 596.

  76. Pedersen, E. B. and Christensen, W. J. 1975. Catecholamines in plasma and urine in patients with essential hypertension determined by double isotope derivative techniques. Acta Med. Scand. 198, 373.

  77. Philip, T., Cordes, U. and Distler, A. 1979. Adrenergic activity, reactivity to noradrenaline and blood pressure control in essential hypertension.In: Circulating Catecholamines and Blood Pressure. Eds. W. H. Birkenhager and H. E. Falke. Utrecht. Bunge Scientific Publications. p. 39.

  78. Quiram, D. R. and Weinshilboum, R. M. 1976. Catechol O-methyl transferase in rat erythrocyte and three other tissues: Comparison of biochemical properties after removal of inhibitory calcium. J. Neurochem. 27, 1197.

  79. Reid, I. 1978. Is there a brain angiotensin system? Circ. Res. 41, 147.

  80. Reid, J. L., Dean, C. R., Hamilton, C. A., Watson, R., Jones, D. H. and Littler, W. 1978. Relationships between blood pressure, heart rate and plasma noradrenaline.In: Circulating Catecholamines and Blood Pressure. Eds. W. H. Birkenhager and H. E. Falke. Utrecht. Bunge Scientific Publications. p. 11.

  81. Reid, J. L., Dean, C. R. T. and Jones, D. H. 1977. Central actions of hypertensive drugs. Cardiovasc. Med. 2, 1185.

  82. Reid, J. L., Wing, L. M. H., Mathias, C. J., Frankel, H. L. and Neil, E. 1977. The central hypotensive action of clonidine in man: Studies in tetraplegic subjects. Clin. Pharmacol. Ther. 21, 375.

  83. Renzini, V., Brunori, C. A. and Valori, C. 1970. A sensitive and specific fluorimetric method for the determination of noradrenaline and adrenaline in human plasma. Clin. Chim. Acta 39, 387.

  84. Robertson, D., Frölich, J. C., Carr, R. K., Watson, J. T., Hollifield, J. W., Shand, D. G. and Oates, J. A. 1978. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. New Eng. J. Med. 298, 181.

  85. Robertson, D. H., Johnson, G. A., Brillis, G. M., Hill, R. E., Watson, J. T. and Oates, J. A. 1977. Salt restriction increases serum catecholamines and urine normetanephrine excretion. Fed. Proc. 36, 956.

  86. Schneider, F. H., Smith, A. D. and Winkler, H. 1967. Secretion from the adrenal medulla: Biochemical evidence for exocytosis. Br. J. Pharmacol. 31, 94.

  87. Sever, P. S., Okikowska, B., Birch, M. and Tunbridge, R. D. G. 1977. Plasma noradrenaline in essential hypertension. Lancet i, 1978.

  88. Sever, P. S., Peart, W. S., Osikowska, B. A., Davies, I. B., Gordon, D., Meade, T. and Tunbridge, R. D. G. 1979. Plasma noradrenaline in essential hypertension: Racial differences.In: Nervous System and Hypertension. Eds. P. Myer and H. Schmitt. Paris. Flammarion. p. 297.

  89. Simon, N., Franklin, S. S., Bleiffer, H. H. 1972. Clinical characteristics of renovascular hypertension. J. Am. Med. Assoc. 220, 1209.

  90. Skeggs, L. 1977. Biochemical relationships of the renin/angiotensin system.In: Hypertension: Mechanisms, Diagnosis and Management. Eds. J. O. Davis, J. H. Laragh and A. Selwyn. New York. HP Publishing Company. p. 25.

  91. Smith, A. D. 1973. Mechanisms involved in the release of noradrenaline from sympathetic nerves. Br. Med. Bull. 29, 123.

  92. Smith, A. D. 1979. Biochemical studies of the mechanism of release.In: The Release of Catecholamines from Adrenergic Neurones. Ed. D. M. Paton. Oxford. Pergamon. p. 1.

  93. Starke, K. 1977. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1.

  94. Starke, K., Taube, H. D. and Borowski, E. 1977. Pre and postsynaptic receptors in catecholaminergic transmission. Arch. Pharmacol. 297, 543.

  95. Stjarne, L. and Burundin, J. 1975. Dual adrenoreceptor mediated control of noradrenaline secretion from human vasoconstrictor nerves: facilitation by beta receptors. Acta physiol. Scand. 94, 139.

  96. Taube, H. D., Starke, K. and Borowski, E. 1977. Presynaptic receptor systems on the noradrenergic neurones of rat brain. Uaunyn Schmiedeberg's Arch Pharmacol. 299, 123.

  97. Thoa, N. 1973. Synthesis and preferential release of newly formed norepinephrine during increased sympathetic activity.In: Frontiers in Catecholamine Research. Oxford. p. 1.

  98. Thureson-Klein, A. and Klein, R. L. 1975. Evidence for exocytosis from large dense cone vesicles in noradrenergic neurones. 6th Int. Congr. Pharmacol p. 488.

  99. U'Prichard, D. C., Greenberg, D. A. and Snyder, S. 1979. CNS alpha adrenergic receptor binding: Studies with normotensive and spontaneously hypertensive rats.In: Nervous System and Hypertension. Eds. P. Myer and H. Schmitt. Paris. Flammarion. p. 38.

  100. Weber, M. A., Stokes, G. S. and Gain, J. M. 1974. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. J. Clin. Invest. 54, 1403.

  101. Weidmann, P., Hirsch, D., Beretta Piccoli, C., Reubi, F. and Ziegler, W. H. 1977. Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am. J. Med. 62, 209.

  102. Weinshilboum, R. M., Schmitt, H. G., Raymond, F. A., Weidman, W. H. and Elveback, L. R. 1975. Inheritance of very low serum dopamine beta hydroxylase activity. Am. J. Hum. Genet. 27, 573.

  103. Wooten, G. F., Thoa, N. B., Kopin, I. J. and Axelrod, J. 1973. Enhanced release of dopamine beta hydroxylase and norepinephrine from sympathetic nerves by dibutyril cyclic adenosine 35 monophosphate and theophyline Molec. Pharm. 9, 178.

  104. Weinshilboum, R. M. and Raymond, F. A. 1977. Inheritance of low erythrocyte catechol-O-methyl transferase activity in man. Am. J. Hum Genet. 29, 125.

  105. Yamaguchi, N., de Champlain, J. and Nadeau, R. 1977. Regulation of norepinephrine release from cardiac sympathetic fibres in the dog by presynaptic alpha and beta receptors. Circ. Res. 41, 108.

  106. Young, W. J., Kunkel, H. G. and Litwin, S. D., 1967. Studies of the Vi(y2c) subgroup of gamma globulin. J. exp. Med. 125, 177.

  107. Ziegler, M., Lake, R. and Kopin, I. 1977. The sympathetic nervous system defect in primary orthostatic hypertension. New Eng. J. Med. 296, 293.

Download references

Author information

Additional information

Review article contributed by invitation.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

FitzGerald, G.A. Neurogenic aspects of essential hypertension in man. I.J.M.S. 148, 280–289 (1979). https://doi.org/10.1007/BF02938100

Download citation

Keywords

  • Clonidine
  • Essential Hypertension
  • Plasma Renin Activity
  • Adrenal Medulla
  • Plasma Noradrenaline